Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BAZ2B | Q9UIF8 | 9/20 | 0.52 |
| ▸ | BAZ2A | Q9UIF9 | 9/20 | 0.52 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | FNTA | P49354 | 6/20 | 0.46 |
| ▸ | FNTB | P49356 | 6/20 | 0.46 |
| ▸ | BRD4 | O60885 | 2/20 | 0.43 |
| ▸ | BRD9 | Q9H8M2 | 2/20 | 0.43 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.42 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26301296 | 0.94 | FNTA (0.51) | BAZ2BBAZ2ABACE1FNTAFNTB | |
| SCHEMBL26301363 | 0.90 | FNTA (0.57) | BAZ2BBAZ2ABACE1FNTAFNTB | |
| SCHEMBL26301329 | 0.90 | FNTA (0.53) | BAZ2BBAZ2ABACE1FNTAFNTB | |
| SCHEMBL26300894 | 0.88 | CYP2C8 (0.42) | BAZ2BBAZ2ABACE1CYP2C8 | |
| SCHEMBL26300363 | 0.88 | CYP2C8 (0.42) | BAZ2BBAZ2ABACE1FNTAFNTB | |
| SCHEMBL26301387 | 0.87 | FNTA (0.59) | BAZ2BBAZ2AFNTAFNTBBRD4 | |
| SCHEMBL26302080 | 0.87 | BAZ2B (0.67) | BAZ2BBAZ2ABACE1BRD4BRD9 | |
| SCHEMBL26301335 | 0.87 | BAZ2B (0.46) | BAZ2BBAZ2ABACE1FNTAFNTB | |
| SCHEMBL26301454 | 0.87 | BAZ2B (0.46) | BAZ2BBAZ2ABACE1FNTAFNTB | |
| SCHEMBL26300877 | 0.87 | CYP2C8 (0.43) | BAZ2BBAZ2ABACE1CYP2C8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4233864-A1 | INTERFERON GENE STIMULATOR COMPOSITION COMPRISING INDOLIZINE DERIVATIVE AS ACTIVE INGREDIENT | Ajou University Industry-Academic Cooperation Foundation (KR) | 2023-08-30 | — | — | EP | disclosed |